GEN - Genetic Engineering and Biotechnology News
Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Top 25 Biotech Companies of 2024 - genengnews.com
Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% …
Top 10 Contract Development and Manufacturing Organizations …
Aug 23, 2024 · This year, GEN’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global …
Top 10 Biopharma Takeover Targets of 2024 - genengnews.com
Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while …
Targeting “Proteolethargy” to Restore Protein Mobility May …
Nov 27, 2024 · The newly reported study focused on protein mobility in the context of chronic diseases. The scientists explained that the billions of protein molecules produced in cells must …
StockWatch: Turnaround Lifts GeneDx Stock 3,600%, with …
Sep 30, 2024 · A 45% jump in revenue to $70.514 million, nearly all of it ($68.924 million) revenue from continuing operations at adjusted gross margins of 62%.
Top 10 RNA-Based Biopharmas - genengnews.com
Nov 17, 2021 · In GEN’s initial A-List published in 2018, the top five public companies generated a combined $1.536 billion in revenues for 2017 and the first three quarters of 2018.By …
Recursion to Acquire Exscientia, Combining AI Drug Pioneers
Aug 8, 2024 · Two months earlier, Exscientia pruned its pipeline down to four active drug candidates in therapeutic areas that include inflammatory disease, hematology, and most …
Genes Activating Old Neural Stem Cells May Counteract Decline …
Oct 2, 2024 · The study results could point to some intriguing next steps in addressing this old neural stem cell passivity—or even stimulating neurogenesis in younger brains in need of …
Wave Clinical Trial Shows First Successful RNA Editing in Humans
Oct 16, 2024 · Wave Life Sciences said today its alpha-1 antitrypsin deficiency (AATD) candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by …